215 related articles for article (PubMed ID: 9262037)
1. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis.
Malik IA; Moid I; Haq S; Sabih M
J Pain Symptom Manage; 1997 Aug; 14(2):82-7. PubMed ID: 9262037
[TBL] [Abstract][Full Text] [Related]
2. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy.
Lalla RV; Gordon GB; Schubert M; Silverman S; Hutten M; Sonis ST; LeVeque F; Peterson DE
Support Care Cancer; 2012 Aug; 20(8):1797-804. PubMed ID: 21964618
[TBL] [Abstract][Full Text] [Related]
4. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy.
Anderson PM; Schroeder G; Skubitz KM
Cancer; 1998 Oct; 83(7):1433-9. PubMed ID: 9762946
[TBL] [Abstract][Full Text] [Related]
5. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Giles FJ; Miller CB; Hurd DD; Wingard JR; Fleming TR; Sonis ST; Bradford WZ; Pulliam JG; Anaissie EJ; Beveridge RA; Brunvand MM; Martin PJ;
Leuk Lymphoma; 2003 Jul; 44(7):1165-72. PubMed ID: 12916869
[TBL] [Abstract][Full Text] [Related]
6. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Giles FJ; Rodriguez R; Weisdorf D; Wingard JR; Martin PJ; Fleming TR; Goldberg SL; Anaissie EJ; Bolwell BJ; Chao NJ; Shea TC; Brunvand MM; Vaughan W; Petersen F; Schubert M; Lazarus HM; Maziarz RT; Silverman M; Beveridge RA; Redman R; Pulliam JG; Devitt-Risse P; Fuchs HJ; Hurd DD
Leuk Res; 2004 Jun; 28(6):559-65. PubMed ID: 15120931
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
8. Vitamin E in the treatment of chemotherapy-induced mucositis.
Wadleigh RG; Redman RS; Graham ML; Krasnow SH; Anderson A; Cohen MH
Am J Med; 1992 May; 92(5):481-4. PubMed ID: 1580295
[TBL] [Abstract][Full Text] [Related]
9. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients.
Ibrahim EM; al-Mulhim FA
Med Oncol; 1997 Mar; 14(1):47-51. PubMed ID: 9232612
[TBL] [Abstract][Full Text] [Related]
10. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.
Dazzi C; Cariello A; Giovanis P; Monti M; Vertogen B; Leoni M; Tienghi A; Turci D; Rosti G; Nanni O; Rondoni C; Marangolo M
Ann Oncol; 2003 Apr; 14(4):559-63. PubMed ID: 12649101
[TBL] [Abstract][Full Text] [Related]
12. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA
Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811
[TBL] [Abstract][Full Text] [Related]
13. Randomized DoubleBlind PlaceboControlled Trial of Propolis for Oral Mucositis in Patients Receiving Chemotherapy for Head and Neck Cancer.
AkhavanKarbassi MH; Yazdi MF; Ahadian H; SadrAbad MJ
Asian Pac J Cancer Prev; 2016; 17(7):3611-4. PubMed ID: 27510017
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis.
Verdi CJ; Garewal HS; Koenig LM; Vaughn B; Burkhead T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jul; 80(1):36-42. PubMed ID: 7552860
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract][Full Text] [Related]
16. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.
Nottage M; McLachlan SA; Brittain MA; Oza A; Hedley D; Feld R; Siu LL; Pond G; Moore MJ
Support Care Cancer; 2003 Jan; 11(1):41-7. PubMed ID: 12527953
[TBL] [Abstract][Full Text] [Related]
17. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy.
Cheng KK; Chang AM
Cancer Nurs; 2003 Dec; 26(6):476-84. PubMed ID: 15022979
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
Elad S; Epstein JB; Raber-Durlacher J; Donnelly P; Strahilevitz J
J Oral Pathol Med; 2012 Mar; 41(3):229-34. PubMed ID: 22077420
[TBL] [Abstract][Full Text] [Related]
19. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial.
Hejna M; Köstler WJ; Raderer M; Steger GG; Brodowicz T; Scheithauer W; Wiltschke C; Zielinski CC
Eur J Cancer; 2001 Nov; 37(16):1994-2002. PubMed ID: 11597376
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.
Allison RR; Ambrad AA; Arshoun Y; Carmel RJ; Ciuba DF; Feldman E; Finkelstein SE; Gandhavadi R; Heron DE; Lane SC; Longo JM; Meakin C; Papadopoulos D; Pruitt DE; Steinbrenner LM; Taylor MA; Wisbeck WM; Yuh GE; Nowotnik DP; Sonis ST
Cancer; 2014 May; 120(9):1433-40. PubMed ID: 24877167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
